Rheumatology 2003; 42: 154-161
© 2003 British Society for Rheumatology
Autoantibodies to dsDNA cross-react with the arginineglycine-rich domain of heterogeneous nuclear ribonucleoprotein A2 (hnRNP A2) and promote methylation of hnRNP A2
Faculty of Medical Technology and Institute of Biotechnology in Medicine, National Yang-Ming University, Taipei,
1 Institute of Marine Biotechnology, National Taiwan Ocean University, Keelung and
2 Institute of Biopharmaceutical Science, National Yang-Ming University, Taiwan, ROC
Objective. This study was designed to clarify the internalization of anti-DNA antibodies (anti-DNA) into living cells in the pathogenesis of systemic lupus erythematosus (SLE) using anti-DNA monoclonal antibodies (mAbs).
Methods. Anti-DNA mAbs 9D7, 9D7D2, 9A4, 5E3F5, 12B3H2 and 6E11E3 were prepared by a standard hybridoma procedure to determine the interaction of anti-DNA with proteins in different types of cells.
Results. The anti-DNA mAbs reacted with two protein antigens (35 and 50 kDa) in the cells. The 35-kDa antigen was shown to have 100% homology with hnRNP A2. The arginineglycine-rich domain in hnRNP A2 was found to be the reaction site, and the methylation of hnRNP A2 by PRMT1 (protein arginine methyltransferase 1) was increased by anti-DNA. Moreover, anti-DNA was demonstrated to bind and internalize into the cytoplasm and nucleus.
Conclusion. Nuclear localizing anti-DNA may cross-react with hnRNP A2 to modulate the inflammatory responses and polarize immune reactions associated with SLE.
KEY WORDS: Antigen, Autoantibody, Epitope, Systemic lupus erythematosus.
Correspondence to: K.-H. Sun, Faculty of Medical Technology and Institute of Biotechnology in Medicine, National Yang-Ming University, 155 Section 2, Lie-Nong Street, Shih-Pai, Taipei, Taiwan 112, ROC. E-mail: ksun{at}ym.edu.tw
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Teerlink ADMA metabolism and clearance Vascular Medicine, July 1, 2005; 10(1_suppl): S73 - S81. [Abstract] [PDF] |
||||
![]() |
T. Teerlink ADMA metabolism and clearance Vascular Medicine, May 1, 2005; 10(2_suppl): S73 - S81. [Abstract] [PDF] |
||||
